242 related articles for article (PubMed ID: 31140715)
1. Population uptake and effectiveness of test-and-treat antiretroviral therapy guidelines for preventing the global spread of HIV: an ecological cross-national analysis.
Mendez-Lopez A; McKee M; Stuckler D; Granich R; Gupta S; Noori T; Semenza JC
HIV Med; 2019 Sep; 20(8):501-512. PubMed ID: 31140715
[TBL] [Abstract][Full Text] [Related]
2. Home testing and counselling to reduce HIV incidence in a generalised epidemic setting: a mathematical modelling analysis.
Ying R; Sharma M; Celum C; Baeten JM; van Rooyen H; Hughes JP; Garnett G; Barnabas RV
Lancet HIV; 2016 Jun; 3(6):e275-82. PubMed ID: 27240790
[TBL] [Abstract][Full Text] [Related]
3. HIV treatment eligibility expansion and timely antiretroviral treatment initiation following enrollment in HIV care: A metaregression analysis of programmatic data from 22 countries.
Tymejczyk O; Brazier E; Yiannoutsos C; Wools-Kaloustian K; Althoff K; Crabtree-Ramírez B; Van Nguyen K; Zaniewski E; Dabis F; Sinayobye JD; Anderegg N; Ford N; Wikramanayake R; Nash D;
PLoS Med; 2018 Mar; 15(3):e1002534. PubMed ID: 29570723
[TBL] [Abstract][Full Text] [Related]
4. High rates of viral suppression in adults and children with high CD4+ counts using a streamlined ART delivery model in the SEARCH trial in rural Uganda and Kenya.
Kwarisiima D; Kamya MR; Owaraganise A; Mwangwa F; Byonanebye DM; Ayieko J; Plenty A; Black D; Clark TD; Nzarubara B; Snyman K; Brown L; Bukusi E; Cohen CR; Geng EH; Charlebois ED; Ruel TD; Petersen ML; Havlir D; Jain V
J Int AIDS Soc; 2017 Jul; 20(Suppl 4):21673. PubMed ID: 28770596
[TBL] [Abstract][Full Text] [Related]
5. Universal test and treat is not associated with sub-optimal antiretroviral therapy adherence in rural South Africa: the ANRS 12249 TasP trial.
Iwuji C; McGrath N; Calmy A; Dabis F; Pillay D; Newell ML; Baisley K; Porter K
J Int AIDS Soc; 2018 Jun; 21(6):e25112. PubMed ID: 29890048
[TBL] [Abstract][Full Text] [Related]
6. Changes in rapid HIV treatment initiation after national "treat all" policy adoption in 6 sub-Saharan African countries: Regression discontinuity analysis.
Tymejczyk O; Brazier E; Yiannoutsos CT; Vinikoor M; van Lettow M; Nalugoda F; Urassa M; Sinayobye JD; Rebeiro PF; Wools-Kaloustian K; Davies MA; Zaniewski E; Anderegg N; Liu G; Ford N; Nash D;
PLoS Med; 2019 Jun; 16(6):e1002822. PubMed ID: 31181056
[TBL] [Abstract][Full Text] [Related]
7. Rapid CD4 decline prior to antiretroviral therapy predicts subsequent failure to reconstitute despite HIV viral suppression.
Darraj M; Shafer LA; Chan S; Kasper K; Keynan Y
J Infect Public Health; 2018; 11(2):265-269. PubMed ID: 28826735
[TBL] [Abstract][Full Text] [Related]
8. High CD4 counts associated with better economic outcomes for HIV-positive adults and their HIV-negative household members in the SEARCH Trial.
Jakubowski A; Snyman K; Kwarisiima D; Sang N; Burger R; Balzer L; Clark T; Chamie G; Shade S; Cohen C; Bukusi E; Charlebois E; Kamya M; Petersen M; Havlir D; Thirumurthy H
PLoS One; 2018; 13(6):e0198912. PubMed ID: 29944678
[TBL] [Abstract][Full Text] [Related]
9. Immediate and long-term outcomes after treat-all among people living with HIV in China: an interrupted time series analysis.
Wu X; Wu G; Ma P; Wang R; Li L; Sun Y; Xu J; Li Y; Zhang T; Li Q; Yang Y; Wang L; Xin X; Qiao Y; Fang B; Lu Z; Zhou X; Chen Y; Liu Q; Fu G; Wei H; Huang X; Su B; Wang H; Zou H
Infect Dis Poverty; 2023 Aug; 12(1):73. PubMed ID: 37580822
[TBL] [Abstract][Full Text] [Related]
10. Using plasma viral load to guide antiretroviral therapy initiation to prevent HIV-1 transmission.
Murnane PM; Hughes JP; Celum C; Lingappa JR; Mugo N; Farquhar C; Kiarie J; Wald A; Baeten JM;
PLoS One; 2012; 7(11):e51192. PubMed ID: 23250272
[TBL] [Abstract][Full Text] [Related]
11. Treatment eligibility and retention in clinical HIV care: A regression discontinuity study in South Africa.
Bor J; Fox MP; Rosen S; Venkataramani A; Tanser F; Pillay D; Bärnighausen T
PLoS Med; 2017 Nov; 14(11):e1002463. PubMed ID: 29182641
[TBL] [Abstract][Full Text] [Related]
12. Trends in and correlates of CD4+ cell count at antiretroviral therapy initiation after changes in national ART guidelines in Rwanda.
Mutimura E; Addison D; Anastos K; Hoover D; Dusingize JC; Karenzie B; Izimukwiye I; Mutesa L; Nsanzimana S; Nash D;
AIDS; 2015 Jan; 29(1):67-76. PubMed ID: 25562492
[TBL] [Abstract][Full Text] [Related]
13. High levels of viral load monitoring and viral suppression under Treat All in Rwanda - a cross-sectional study.
Ross J; Ribakare M; Remera E; Murenzi G; Munyaneza A; Hoover DR; Shi Q; Nsanzimana S; Yotebieng M; Nash D; Anastos K;
J Int AIDS Soc; 2020 Jun; 23(6):e25543. PubMed ID: 32536033
[TBL] [Abstract][Full Text] [Related]
14. Temporal trends of population viral suppression in the context of Universal Test and Treat: the ANRS 12249 TasP trial in rural South Africa.
Larmarange J; Diallo MH; McGrath N; Iwuji C; Plazy M; Thiébaut R; Tanser F; Bärnighausen T; Orne-Gliemann J; Pillay D; Dabis F;
J Int AIDS Soc; 2019 Oct; 22(10):e25402. PubMed ID: 31637821
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the clinical outcomes of the Test and Treat strategy to implement Treat All in Nigeria: Results from the Nigeria Multi-Center ART Study.
Stafford KA; Odafe SF; Lo J; Ibrahim R; Ehoche A; Niyang M; Aliyu GG; Gobir B; Onotu D; Oladipo A; Dalhatu I; Boyd AT; Ogorry O; Ismail L; Charurat M; Swaminathan M
PLoS One; 2019; 14(7):e0218555. PubMed ID: 31291273
[TBL] [Abstract][Full Text] [Related]
16. The impact of population dynamics on the population HIV care cascade: results from the ANRS 12249 Treatment as Prevention trial in rural KwaZulu-Natal (South Africa).
Larmarange J; Diallo MH; McGrath N; Iwuji C; Plazy M; Thiébaut R; Tanser F; Bärnighausen T; Pillay D; Dabis F; Orne-Gliemann J;
J Int AIDS Soc; 2018 Jul; 21 Suppl 4(Suppl Suppl 4):e25128. PubMed ID: 30027600
[TBL] [Abstract][Full Text] [Related]
17. HIV treatment outcomes among people who acquired HIV via injecting drug use in the Asia-Pacific region: a longitudinal cohort study.
Han WM; Jiamsakul A; Salleh NAM; Choi JY; Huy BV; Yunihastuti E; Do CD; Merati TP; Gani YM; Kiertiburanakul S; Zhang F; Chan YJ; Lee MP; Chaiwarith R; Ng OT; Khusuwan S; Ditangco R; Kumarasamy N; Sangle S; Ross J; Avihingsanon A;
J Int AIDS Soc; 2021 May; 24(5):e25736. PubMed ID: 34021711
[TBL] [Abstract][Full Text] [Related]
18. Risk for Non-AIDS-Defining and AIDS-Defining Cancer of Early Versus Delayed Initiation of Antiretroviral Therapy : A Multinational Prospective Cohort Study.
Chammartin F; Lodi S; Logan R; Ryom L; Mocroft A; Kirk O; d'Arminio Monforte A; Reiss P; Phillips A; El-Sadr W; Hatleberg CI; Pradier C; Bonnet F; Law M; De Wit S; Sabin C; Lundgren JD; Bucher HC;
Ann Intern Med; 2021 Jun; 174(6):768-776. PubMed ID: 33721519
[TBL] [Abstract][Full Text] [Related]
19. Late HIV Diagnosis but Earlier Antiretroviral Treatment Initiation in Northwest Spain: Impact of Current Treatment Guidelines.
Cid-Silva P; Margusino-Framiñán L; Balboa-Barreiro V; Pernas-Souto B; Mena-De-Cea Á; Martín-Herranz I; Castro-Iglesias Á; Poveda E
J Int Assoc Provid AIDS Care; 2019; 18():2325958218821940. PubMed ID: 30798655
[TBL] [Abstract][Full Text] [Related]
20. From CD4-Based Initiation to Treating All HIV-Infected Adults Immediately: An Evidence-Based Meta-analysis.
Song A; Liu X; Huang X; Meyers K; Oh DY; Hou J; Xia W; Su B; Wang N; Lu X; Xia H; Yang X; Chen H; Wu H
Front Immunol; 2018; 9():212. PubMed ID: 29487595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
